Product Overview Intelletual expergt system of “cloud” level Emergent feature of the “cloud”: regional and country-level statistics and evolution of population health
Competitive Advantage• Communication channels of MDD are based on international Standard IEEE 802.15.6 for wireless communications for medical sensor networks. Authors possess basic patents on the method of ultrawideband communications used in this Standard and its implementation (bundle of 5 Russian patents : № 2185032, № 2276458, № 2273100, № 2293438, № 2327278, and 4 foreign patents: Ukraine № 71675, South Korea № 0472114, Canada № 2416702, Europatent № 1304824)• The device will be equipped with unique intellectual interactive medical (inquiry) analytical system, which perfects itself with time by means of data accumulation. Solution prototypes are protected by 3 official software registration certificates (№ 2009616940, №2011610345, № 2012610881).• Authors of the Project possess a bundle of patents and patent applications for a number of sensors used in the proposed MDD: № 2434574, №2342067, №2354946, RF №2010137514, RF № 2010151678, RF № 2012108456, PCT/RU2011/000682)
Business ModelCommercialization:• B2B: medical facilities of general practice, including periodic medical screening; health examination and monitoring; school medical offices, organization of equipment usage courses for medical staff.• B2C: insurance medicine, lending MDD by clinics to patients; commercial rental; individual sales; audio and video user guides.• B2G.
Team Dmitriev A.S., Head of the Project, Dr.Sci., Professor, twice Antziperov V.E., Ph.D., specialist prizewinner of the State Award on methods of remote medical of the USSR Council of diagnostics and telemedicine Ministries Belyi Yu.N., Dr.Sci., Professor, specialist on pharmacology and biomedical electronics Petukhov S.V., Dr.Sci., prizewinner Kuzmin L.V., Dr.Sci., specialist on of the USSR State Award, specialist UWB communications and on wireless sensor networks bioinformatics, biophysics, numeric al simulation of biological systems
PartnersScience and technology partners IRE RAS MIPT IM RASTechnology partners NanoXaos Angstrem-TMedicine partners IMBP RAS Burdenco Semashko CMCH Hospital of IMT RAMS FSCC FMBA RZhD Co
Road Map FINANCING STAGES Year 1 Year 2 Year 3 Year 4 Year 5 Investment 30 000 150 000 360 000 750 000 – Capitalization, thousand rubl. 1 428 000 5 700 000 Sale of Sale of Investor exit company company